🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Achondroplasia

Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy) NCT05328050n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Registry VIrtual STudy in Achondroplasia for the US (VISTA) NCT06168201n/a8 sites📍 Oakland📍 San Francisco📍 Baltimore BioMarin Pharmaceutical A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia NCT06079398Phase 218 sites📍 Saint Paul📍 Houston📍 Madison Ascendis Pharma A/S · Tests: Navepegritide, Placebo for Navepegritide Achondroplasia Natural History Multicenter Clinical Study NCT02597881n/a1 site📍 Baltimore Johns Hopkins University Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia NCT07388966n/a4 sites📍 Liège📍 Liège📍 Paris SYSNAV A Study of TYRA-300 in Children With Achondroplasia: BEACH301 NCT06842355Phase 225 sites📍 Torrance📍 Aurora📍 Wilmington Tyra Biosciences, Inc · Tests: TYRA-300 0.125 mg/kg, TYRA-300 0.25 mg/kg, TYRA-300 0.375 mg/kg, TYRA-300 0.50 mg/kg, TYRA-300 0.625 mg/kg A Study in Children With Achondroplasia NCT07301463n/a8 sites📍 Beijing📍 Guangzhou📍 Zhengzhou Abbisko Therapeutics Co, Ltd · Tests: No Interventions, complete a natural history observation of ACH for at least 6 months and up to 2 years Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) NCT07169279Phase 212 sites📍 Oakland📍 Baltimore📍 Madison QED Therapeutics, a BridgeBio company · Tests: Infigratinib is provided as a single dose of minitablets for oral administration, Infigratinib is provided as sprinkle … Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia NCT07441876Phase 2, Phase 328 sites📍 Oakland📍 Wilmington📍 Chicago BioMarin Pharmaceutical · Tests: BMN 333, Vosoritide Injection [Voxzogo]
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy